Perfluorocarbon may improve biosensor accuracy:
This article was originally published in Clinica
Synthetic Blood International has received a notice of allowance on a US patent application covering the use of a perfluorocarbon emulsion as an O(2) reservoir in a biosensor. O2 is a critical substrate for most biosensors, says the Costa Mesa, California firm, which is developing an implanted glucose biosensor for monitoring diabetic patients. Because O2 levels are typically very low in tissue, it is believed that the a perfluorocarbon emulsion will increase available oxygen and improve accuracy in low-oxygen biosenor applications.
You may also be interested in...
UCB's R&D efforts include late-stage diverse but complementary immunologicals and anti-neuroinflammatories.
Janssen and AstraZeneca are among a raft of companies that might this week find out whether the European Medicines Agency will recommend approval of their products for expanded therapeutic indications.
Shares in Iovance Biotherapeutics have soared this week amid reports the US clinical-stage biotechnology company is in active M&A talks.